Alpha Teknova (TKNO) Return on Capital Employed (2021 - 2026)
Alpha Teknova (TKNO) reported Return on Capital Employed of 17.31% for Q1 2026, down 1492.0% year-over-year from 1.24% in Q1 2025, and little changed quarter-over-quarter from 17.31% in Q4 2025.
Alpha Teknova (TKNO) Return on Capital Employed (2021 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 6 years of Return on Capital Employed data on file, last reported at 17.31% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 17.31%, down 1492.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 17.31% (down 1492.0% YoY), and the FY2025 annual result was 16.38%, down 1137.0% from the prior year.
- Return on Capital Employed was little changed at 17.31% in Q1 2026 per TKNO's latest filing, from 17.31% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 2.46% in Q3 2025 and troughed at 49.14% in Q2 2023.
- A 5-year average of 20.99% and a median of 25.29% in 2022 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2025: Return on Capital Employed tumbled 3680 bps in 2023, then surged 3099 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 34.16% in 2022, then gained by 16 bps to 28.54% in 2023, then soared by 82 bps to 5.11% in 2024, then sank by 239 bps to 17.31% in 2025, then grew by 0 bps to 17.31% in 2026.
- Business Quant data shows TKNO's Return on Capital Employed at 17.31% in Q1 2026, 17.31% in Q4 2025, and 2.46% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Alpha Teknova | 239.62 Mn | 221.84 Mn | 3.78 Mn | -17.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.31% |
| Dec 31, 2025 | -17.31% |
| Sep 30, 2025 | 2.46% |
| Jun 30, 2025 | -0.85% |
| Mar 31, 2025 | -2.39% |
| Dec 31, 2024 | -5.11% |
| Sep 30, 2024 | -28.52% |
| Jun 30, 2024 | -29.55% |
| Mar 31, 2024 | -29.41% |
| Dec 31, 2023 | -28.54% |
| Sep 30, 2023 | -30.63% |
| Jun 30, 2023 | -49.14% |
| Mar 31, 2023 | -38.24% |
| Dec 31, 2022 | -34.16% |
| Sep 30, 2022 | -25.29% |
| Jun 30, 2022 | -12.33% |
| Mar 31, 2022 | -10.47% |
| Dec 31, 2021 | -7.50% |
| Sep 30, 2021 | -3.92% |